@article{cd213fa690d44aee8fcfa03f8760e1f7,
title = "Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy",
abstract = "Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this fifth of 6 sections of the guidelines of care for psoriasis, we discuss the use of ultraviolet (UV) light therapy for the treatment of patients with psoriasis. Treatment should be tailored to meet individual patients' needs. We will discuss in detail the efficacy and safety as well as offer recommendations for the use of phototherapy, including narrowband and broadband UVB and photochemotherapy using psoralen plus UVA, alone and in combination with topical and systemic agents. We will also discuss the available data for the use of the excimer laser in the targeted treatment of psoriasis. Finally, where available, we will summarize the available data that compare the safety and efficacy of the different forms of UV light therapy.",
author = "Alan Menter and Korman, {Neil J.} and Elmets, {Craig A.} and Feldman, {Steven R.} and Gelfand, {Joel M.} and Gordon, {Kenneth B} and Alice Gottlieb and Koo, {John Y.M.} and Mark Lebwohl and Lim, {Henry W.} and {Van Voorhees}, {Abby S.} and Beutner, {Karl R.} and Reva Bhushan",
note = "Funding Information: Steven R. Feldman, MD, PhD: Dr Feldman served on the advisory board of and was investigator and speaker for Galderma, Stiefel, Warner Chilcott, Abbott Labs, and Astellas, receiving grants and honoraria; served on the advisory board of PhotoMedex, receiving stock options; received grants from National Psoriasis Foundation and Dermatology Foundation, Coria, ASDS, Ortho Pharma, and Roche Dermatology; was an investigator and speaker for Centocor, Connetics, and Genentech, receiving grants and honoraria; was a speaker and consultant for Bristol-Myers Squibb Derm, receiving grants; was an investigator for National Biological Corp, Aventis Pharma, and Graceway, receiving grants; was a consultant for Peplin, receiving honoraria; was a consultant for GSK, receiving honoraria; was a consultant for Pharmaderm, receiving grants; was a consultant and investigator for Neostrata, receiving grants and honoraria; was a speaker for Novartis, receiving grants; and is the founder and shareholder of DrScore.com , receiving stock. He received separate department funding from Acuderm, Advanced Tissue Sciences, Allergan, Aventis, Bristol-Myers Squibb, Combe, Curatek, Ferndale, Fujisawa, Galderma, Genderm, Glaxo Wellcome, Hermal, Hill, Hoffman LaRoche, Janssen, Mayrand, Neostrata, Neutrogena, Novartis, Oclassen, Ortho, Person & Covey, Proctor & Gamble, RJR Nabisco, Schering-Plough, Shelton, SmithKline, Stiefel, 3M, United Catalyst, Upjohn, and Wolff Systems. ",
year = "2010",
month = jan,
doi = "10.1016/j.jaad.2009.08.026",
language = "English (US)",
volume = "62",
pages = "114--135",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "1",
}